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SUMMARY.-A 17-year-old patient with a small paratesticular embryonic
sarcoma presented with symptoms of renal failure, polyuria and widespread
bone metastases. Investigation revealed hypercalcaemia and uraemia without
any evidence of hyperparathyroidism. The hypercalcaemia responded over a
period of weeks to administration of mithramycin with initial improvement in
the symptoms and metabolic derangements. Control was lostwiththe necrosis
of intra-abdominal tumour deposits and haemorrhagic polypoid deposits in the
alimentary tract. The value and hazards ofmithramycin arewelldemonstrated
by these rare complications of this type of tumour.
MITHRAMYCIN is an antibiotic with cytotoxic activity derived from an
actinomycete of the Streptomyces genus. The drug acts like Actinomycin D by
inhibiting DNA directed DNA synthesis (Yarbro, Kennedy and Barnum, 1966).
Its established clinical importance is in the treatment of testicular neoplasms
(Kennedy, Griffen and Lober, 1965; Brown and Kennedy, 1965). In addition it
has been suggested that the drug may be of value in the emergency treatment of
hypercalcaemia (Parsons, Baum and Self, 1967). Itshypocalcaemic effect appears
to be due to blocking of the peripheral action of parathyroid hormone (PTH) or
tumour produced PTH peptides on gut and bone. Mithramycin has been used
for this purpose in a few cases producing temporary lowering of life endangering
serum calcium levels (Baum, 1968; Edwards and Besser, 1968; Ream et al., 1968;
Perlia et al., 1969; Singer et al., 1970).
The patient about to be described provided a unique opportunity to study the
effect of mithramycin on a patient with a paratesticular tumour presenting with
renal failure secondary to hypercalcaemia.
CASE REPORT
The patient, a 17-year-old student, was referred to the hospital with a history
of recent weight loss of 10 kg. in 3 weeks. He had suffered from nausea and
vomiting for a similar length of time. For the preceding 2 months he had
complained of general lethargy, pains in the hips and bilateral conjunctivitis.
EXPLANATION OF PLATE
FIG. I.-Radiographic views of the pelvis showing widespread skeletal metastases.
FIG. 2.-Renal biopsy stained with alizarin red and methylene blue showing widespread
calcium deposits in the tubules.BRITISH JOUCRNAL OF CANCER.
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Direct questioning revealed that the patient was excessively thirsty and had
polyuria with nocturia. There was no past history of renal disease, excessive
intake of vitamins or alkalis. There was no family history of endocrine disease,
renal calculi or malignant disease.
On examination the patient appeared a well nourished afebrile youth with
severe crystal conjunctivitis (Berlyne and Shaw, 1968), maximal in the limbus of
both eyes. There was enlargement of the liver, the edge extending 6 cm. below
the costal margin. A painless, solid mass 5 cm. in diameter was detected in the
left scrotum. This swelling had been noticed by the patient for about 6 months
but not considered worth mentioning. His blood pressure was 130/80. His fundi
showed no remarkable changes, there was no band keratopathy. There was bone
tenderness over the pelvis and moderate quadriceps wasting bilaterally. There
was no sensory neuropathy to simple testing.
Investigations on admission: Hb. 11-3 g. %, WBC 14,900/cu.mm., ESR 55 mm./
hour, Urea 190 mg. %, Serum Na 138 mEq/litre, K 4*0 mEq/litre, HCO3 21 mEq/
litre, Ca 15.1 mg. %, P04 5-6 mg. %. Acid phosphatase 3 K-A units, alkaline
phosphatase 9 K-A units. Chest X-ray showed miliary shadowing in both lung
fields and a pelvis radiograph revealed widespread osteolytic lesions in the pelvis
and upper femora (Fig. 1). A renal biopsy showed extensive calcium deposition
in the lumens and basement membrane ofthe collecting and distal tubules and in
the basement membrane of Bowman's capsule (Fig. 2).
Clinical progress
A course of steroids, 150 mg. of hydrocortisone daily for 10 days, was initiated
without appreciable hypocalcaemic effect. A left radical orchidectomy was
performed and a tumour 5 cm. in diameter was found in the paratesticular tissue
at the lower pole of the testis, separate from both the testis and the epididymis.
Sections showed an undifferentiated spindle celled sarcoma. Cross striations were
not found and the appearances were those of a paratesticular embryonic sarcoma
of the type described by Patton and Horn (1962). Mithramycin was then given
by continuous intravenous infusion at a dose of25 ,tg./kg. dailyfor 8 days. There
was a marked subjective improvement together with objective improvement of
the eye signs. The effect on the serum and urinary calcium is shown in Fig. 3.
Within a week ofstopping the drug the patient's condition deteriorated and three
more short courses of treatment were given atweekly intervals. After each course
there was a temporary improvement in signs and symptoms coincident with the
lowering of serum calcium. Over this period the patient continued to lose weight
and there was no reduction in the size ofthe bony metastases as judged by serial
radiographs; however he managed to return home for a period.
Seven weeks after his first admission the patient developed abdominal pain
with signs maximal in the right iliac fossa. At operation, multiple enlarged
mesenteric lymph nodes were found and a normal appendix was removed. Bone
pain was now becoming more troublesome and the patient received blood trans-
fusions to compensate for an increasing normochronic, normocytic anaemia, a
common complication of mithramycin therapy (Kennedy, 1970). Terminally
the patient developed severe abdominal pain and distension, at the same time as
the appearance ofelevated serum lacticdehydrogenase levels (Fig. 3). A diagnosis
of necrosis of intra-peritoneal tumour deposits was made and the patient died
shortly afterwards, 11 weeks after his first admission.
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FIa. 3.-Metabolic measurements made during administration of hydrocortisone and mithramycin.
Autopsyfindings
The body was that of a thin young man, height 198 cm. The marrow ofthe
thoracic and lumbar vertebrae, the femur and sternum, was extensively replaced
by white metastic tumour. The paraortic lymph nodes were also replaced by
tumour, forming a confluent massextending fromthe coeliac axistothebifurcation
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of the aorta. Tumour nodules were present in the following: the surface and
lower lobe of each lung, the liver, one adrenal, the mucosa of the stomach, small
and large intestines. Death was due to intersusception of the ileum caused by
one of the tumour nodules. Sections of all the tumour nodules showed partly
necrotic spindle celled sarcoma, with a similar microscopical structure to that of
the primary.
DISCUSSION
The patient presented with a mixed picture of the effects of hypercalcaemia,
renal failure and widespread tumour deposits. The incidence of hypercalcaemia
in malignant testicular tissue tumours is not known but several instances of
moderately raised plasms calcium concentrations have been recorded (Ream et al.,
1968).
The moderate degree of polyuric renal failure is certainly due to the effect of
the hypercalcaemia and calcium deposition in the tubules and vessels (Epstein,
1968).
The failure of steroids to lower the serum calcium is not an uncommon pheno-
menon where the deposits are widespread or when the tumour is secreting para-
thyroid hormone-like peptides.
The metabolic effects of treatment are shown in Fig. 3. The hypercalcaemia
responded to the giving of mithramycin with a lowering of the blood urea which
was reflected in a steady increase in the urinary calcium despite lower mean serum
calcium concentrations. Similar findings have been reported in treating a
patient with carcinoma of the lung with hypercalcaemia with Actinomycin D
(Muggia and Heinemann, 1970). Phosphate concentrations were not influenced
by therapy and were not out of proportion to the urea retention. This, coupled
with the normal alkaline phosphatase concentration at the outset ofthe investiga-
tion, suggested that this tumour was not producing a parathyroid hormone-like
peptides (Sherwood et al., 1967). The rise in alkaline phosphatase from normal
concentrations is associated with a lowering of the serum calcium and then after
the end ofOctober, despite continued bouts ofhypercalcaemia, there was a steady
decline. This dissociation of alkaline phosphatase and serum calcium concentra-
tion suggests that after the first response to therapy there was healing ofbone with
the production of alkaline phosphatase, the slight but sustained increase in total
urinary hydroxyproline to between 100 and 150 mg. per 24 hours could be linked
with the healing process. The return to pre-treatment values of alkaline phos-
phatase just before the patient died is accompanied by increasing concentrations
ofLDH probably oftumour origin as large areas underwent necrosis (Baum, 1968).
The urinary calcium remained high throughout reflecting the interaction between
renal failure and the hypercalcaemia; the only relatively low concentrations were
observed after the initial lowering of the serum calcium concentration and the
possible healing of the bone lesions. Exactly the opposite relationship between
the alkaline phosphatase and total urinary hydroxyproline excretion has been
recorded following the removal of a parathyroid adenoma (Smith, 1969), a further
indication that this tumour was not producing parathyroid hormone peptides.
The general prognosis of this type of tumour is poor, the age of incidence and
pathological features mark it out from the other connective tissue and muscle
tumours ofthe paratesticular tissues (Gowing and Morgan, 1964).
309310 V. PARSONS, G. SCOTT, M. BAUM, E. MOLLAND AND J. MAKIN
We would like to thank Dr. K. Budd from whom mithramycin was obtained
through Pfizer Ltd., Sandwich, bytheJohn L. SmithMemorialfor Cancer Research
under contract PH 43/64/50. Grateful thanks are due to Mrs. C. Davies for
technical assistance, supported by the Research Committee of King's College
Hospital.
REFERENCES
BAUM, M.-(1968) Br. J. Cancer, 22, 176.
BERLYNE, G. AND SHAW, A. B.-(1968) Lancet, ii, 366.
BROWN, J. H. AND KENNEDY, B. J.-(1965) New Engl. J. Med., 272, 111.
EDWARDS, C. R. W. AND BESSER, G. M.-(1968) Br. med. J., 3, 167.
EPSTEIN, F. H.-(1968) Am. J. Med., 45, 700.
GowING, N. F. C. AND MORGAN, A. D.-(1964) Br. J. Urol., 36, Suppl. 'Pathology
of Testicular Tumours,' edited by D. H. Collins and R. C. B. Pugh, Ch. 8, p. 78.
KENNEDY, B. J.-(1970) Am. J. MIed., 49, 494.
KENNEDY, B. J., GRIFFEN, JNR. W. 0. AND LOBER, P.-(1965) Cancer Chemother. Rep.,
18, 1631.
MUGGIA, F. M. AND HEINEMANN, H. O.-(1970) Ann. intern. Med., 73, 281.
PARSONS, V., BAUM, M. AND SELF, M.-(1967) Br. med. J., i, 474.
PATTON, R. B. AND HORN, R. C.-(1962) Surgery, St. Louis, 52, 572.
PERLIA, C. P., GUBISH, N. J., WOLTER, J., EDELBERG, D., DEDERICK, M. M. AND TAYLOR,
S. G.-(1969) Ann. intern. Med., 70, 1103.
REAM, W. W., PERLIA, C. P., WOLTER, J. AND TAYLOR, S. G.-(1968) J. Am. med. Ass.,
204, 1030.
SHERWOOD, L. M., O'RIORDAN, J. L. H., AURBACH, G. D. et al.-(1967) J. clin. Endocr.
Metab., 27, 140.
SINGER, F. R., NEER, R. M., MURRAY, T. M., KEUTMANN, H. T., DEFTOS, L. J. AND
POTTS, J. T. (1970) New Engi. J. Med., 283, 634.
SMITH, R. (1969) Clinica chim. Acta, 23, 421.
YARBRO, J. W., KENNEDY, B. J. AND BARNUM, C. P. (1966) Cancer Res., 26, 36.